Cytarabine (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Cytarabine (HCl) Manufacturers of Cytarabine (HCl) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Cytarabine (HCl)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 100 mg/sq.meter180 (183)As recommended.IV InfFor 5 days. Repeated every 2 weeks total 12 doses Paedriatic Dosage (20kg) 70 to 200 mg/sq.meter140 (135)24 hourlyIntra VenousMaintenance for 2-5 days per month200 mg/sq.meter370 (367)24 hourlyIntra VenousInitially for 5 days for induction per 2 weeks Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Cytarabine (HCl) is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Cytarabine (HCl) Back to top Manufacturers of Cytarabine (HCl) in Pakistan Atco Bio Pharma Highnoon Pfizer Pharmedic Back to top Previous Drug Generic - Next Drug Generic